Hey, Alexa, can anything stop Amazon?
Shares of the e-commerce king, which is also now a cloud computing giant, connected-home leader, drone company, freight airline, Hollywood studio and even a traditional brick-and-mortar retailer, rose above $900 for the first time Tuesday.
It’s another all-time high.
Amazon (AMZN, Tech30) stock is on a seven-day winning streak.....More>>>
Dollar General (DG) marked its 27th consecutive year of same-store sales growth in fiscal 2016. It followed this milestone up with a beat on both the top and bottom lines during its first quarter of 2017, with comps once again growing – but by only about 0.7%. As I was sifting through the retail carnage, Dollar General was one of the companies that stood out as above average, so I decided....More>>>
The parent company of Sears and Kmart, which has been paring costs and hoarding cash in a bid to survive, said Tuesday that it will put off repaying much of a $500 million loanto help shrink its debt.
Subsidiaries of Sears Holdingnow have a deal that will allow them to pay back $100 million of a $500 million loan in July, the initial date of maturity. But the remaining $400 million will not....More>>>
GOP Proposes Radical Change to 401(k) System
5 Uses for Life Insurance That Most People Haven’t Thought Of
What to Make of Merrill’s Reorg, New Ads
Bank of America’s first-quarter profits jumped 40% to $4.86 billion, up from $3.47 billion a year ago. Per-share earnings were $0.41, beating estimates and last year’s $0.38 EPS.
Revenue rose 7% to....More>>>
Although several obesity drugs are now on the market, they haven’t caught on nearly as much as biopharmaceutical companies had hoped they would. Investors looking to buy obesity-drug stocks are better off finding companies that also have other products either on the market or in development.
Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY)....More>>>
As unexpected as Donald Trumps presidential election, consumers expressed much more positive economic expectations following his victory.
While the surge in confidence ended by mid-December, it nonetheless led to the highest level of the Sentiment Index since January 2004, according to the University of Michigan Surveys of Consumers.
An all-time record number....More>>>
In my September article last year on Navios Maritime Partners (NYSE:NMM) – What’s going on?, I gave an update on where I believe the company was standing, and what could be reasonably expected to happen going forward.
Steady as she goes
The dry-cargo bulk market has been quite resilient. The demand fluctuate every week. Nevertheless, there are two very powerful forces in....More>>>
Protalix BioTherapeutics (NYSE:PLX) is a clinical/commercial biotech company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx platform. More details about the company can be found in my December 28, 2016, article, “Protalix BioTherapeutics Receives $24M Order, Is Well Funded, And Has Significant Upside.”